De Prisco M, Tapoi C, Oliva V, Strumila R, Takami C, Girone N, Macellaro M, de Salles Andrade JB, Schmitz C, Vieta E, Fico G. Clinical impact of obsessive-compulsive disorder comorbidity in bipolar disorder: a systematic review and meta-analysis. Eur Psychiatry. 2025 Aug 26. [Epub ahead of print] :1-34.
Gebest M, Weiss C, Cho CG, Hausner L, Frölich L, Förster A, Santhanam N, Fontana J, Groden C, Wenz H, Maros ME. Longitudinal automated brain volumetry versus expert visual assessment of atrophy progression on MRI: an exploratory study. Sci Rep. 2025 15(1):14968.
Gründer G, Mertens L, Jungaberle A, Jungaberle H, Spangemacher M. Compassionate use of psilocybin for treatment-resistant depression in Germany. Lancet Psychiatry. 2025 Sep 18. [Epub ahead of print]
Meinhardt M, Skorodumov I, Jeanblanc J, Benvenuti F, Hilal FF, Domi E, André C, Bodeau S, Jeanblanc V, Domanegg K, Ciccocioppo R, Naassila M, Spanagel R. A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse. Neuropsychopharmacology. 2025 50(6):886-894. Epub 2025 Feb 28.
Mlynek E, Tan X, Lammertz SE, Schaffrath S, Gründer G, Schneider F, Frodl T, Mathiak K, Gaebler AJ. Disturbed Functional Connectivity Between Anterior Default Mode and Sensory Processing Regions Is Linked to Peripheral Inflammatory Markers and Psychopathology in Schizophrenia. Schizophr Bull. 2025 Apr 23. [Epub ahead of print] 15:153.